Navigation Links
New Study Published in Lancet Respiratory Medicine Highlights QIAGEN's QuantiFERON-TB Potential to Predict Active Tuberculosis Risk in Infants
Date:2/16/2017

HILDEN, Germany and GERMANTOWN, Maryland, February 16, 2017 /PRNewswire/ --

Results Suggest Benefits of Quantitative Screening of Young Children in Countries With High TB Burden 

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that data published in The Lancet Respiratory Medicine journal shows screening with QuantiFERON-TB Gold (QFT) can detect latent tuberculosis (TB) infection in otherwise healthy young children and can predict which are likely to progress to the active stage of this life-threatening respiratory disease.

Continue Reading
QuantiFERON-TB blood test (PRNewsFoto/QIAGEN N.V.)
QuantiFERON-TB blood test (PRNewsFoto/QIAGEN N.V.)

(Photo: http://mma.prnewswire.com/media/468908/QuantiFERON_TB_Blood_Test.jpg )

Results from the study of more than 2,500 young children in South Africa suggest that screening with the modern QuantiFERON-TB blood test could save lives in countries with a high TB burden by identifying those children most at risk of developing active disease. The study noted young children are particularly vulnerable to TB, with up to 20% of those infected by the bacteria developing the active TB disease.

"This study marks a true milestone. For the first time, there is a test that has demonstrated the potential to quantify the risk for young children to develop active tuberculosis. Researchers found that those with a QuantiFERON-TB test result above a certain threshold were far more likely than others to get sick with the active disease. TB is a terrible killer of children in high-burden countries, so early diagnosis and treatment could save many lives," said Dr. Masae Kawamura, Senior Director, TB Medical and Scientific Affairs, at QIAGEN.

Click here for full press release:

https://www.qiagen.com/about-us/press-releases/pressreleaseview?ID={049783C5-174E-41FE-974D-1662A6DBD416}&lang=en

Contacts: QIAGEN Investor Relations John Gilardi +49-2103-29-11711 e-mail: ir@QIAGEN.com Public Relations Dr. Thomas Theuringer +49-2103-29-11826 e-mail: pr@QIAGEN.com


'/>"/>
SOURCE QIAGEN N.V.
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Advocacy Study Highlights Top Locations for High-Growth Companies
2. Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
3. New Study Shows Full Spectrum Endoscopy Procedure Reduces The Miss Rate of Adenomas During Colonoscopy
4. Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak
5. AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
6. Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S.
7. Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain
8. Ceregene Reports Additional Efficacy Data From Parkinsons Disease Phase 2b Study
9. Primary Efficacy and Safety Findings from Phase 3 Study of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
10. Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency
11. Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2019)... N.J. (PRWEB) , ... September 18, 2019 , ... The ... need. They all attended the Youth Consultation Services Foundation (YCS) in Hackensack , ... They also spent time with the children and threw them a pizza party and ...
(Date:9/17/2019)... ... September 17, 2019 , ... AssuriCare LLC , ... RegistryConnect , the first and most compliant online management platform developed for ... recording, client and caregiver relationship management. RegistryConnect is available only to home care ...
(Date:9/17/2019)... ... September 17, 2019 , ... Today, in partnership with Lehman ... and consent with student and faculty from The City University of New York ... Ramirez, MPH; Elise Schuster, MPH; Raffaele M. Bernardo, DO, FACP, AAHIVS and Stuart ...
Breaking Medicine Technology:
(Date:9/18/2019)... Ore. (PRWEB) , ... September 18, 2019 , ... A new study by BestPlaces looks ... . Same-sex marriage is the only Federally-mandated right, so other related rights vary widely across ... Conversion Therapy (trying to change an individual's sexual orientation) , Employment , ...
(Date:9/17/2019)... ... September 17, 2019 , ... ... Keflezighi and the American Heart Association (AHA)-San Diego Chapter to raise awareness of ... Stroke Walk on Saturday, September 21 in Balboa Park alongside National University System ...
(Date:9/17/2019)... , ... September 17, 2019 , ... ... initiative contributing to the long-term health of canines – specifically golden retrievers - ... Golden Retrievers will die from cancer – one out of five retrievers in ...
(Date:9/17/2019)... , ... September 17, 2019 , ... ... join the largest accountable care organization (ACO) in the country, the company announced ... groundbreaking collaboration to improve care quality and increase cost efficiency. This opportunity is ...
(Date:9/17/2019)... ... September 17, 2019 , ... Dr. Perry ... has been certified by the American Academy of Facial Esthetics (AAFE) to administer ... wide range of orofacial conditions such as tooth clenching and grinding, tongue tension, ...
Breaking Medicine News(10 mins):